A prospective randomized, double-blind, sham-controlled, multicenter, Phase 3 study of OTO- 201 given as a single intratympanic injection for intra-operative treatment of middle ear effusion in pediatric subjects requiring tympanostomy tube placement

Awarded By

Contributors

Start/End

  • April 1, 2014 - October 21, 2014